A novel approach to partition central and peripheral airway nitric oxide

Chest

Volumn 145, Issue 1, 2014, Pages 113-119

  Paredi, Paolo ^a   Kharitonov, Sergei A ^a   Meah, Sally ^a   Barnes, Peter J ^a   Usmani, Omar S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; AIRWAY DYNAMICS; ARTICLE; ASTHMA; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EXHALATION; EXHALATION FLOW RATE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG GAS EXCHANGE; MALE; MATHEMATICAL MODEL; NITRIC OXIDE CONCENTRATION EXHALATION TIME PLOT; NITRIC OXIDE PARTITIONING; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY TRACT PARAMETERS;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHI; BRONCHIOLES; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; YOUNG ADULT;

EID: 84892653044     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0843     Document Type: Article

References (37)

1. Barnes PJ, Dweik RA, Gelb AF, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010; 138 (3): 682-692.
2. Lim KG, Mottram C. The use of fraction of exhaled nitric oxide in pulmonary practice. Chest. 2008; 133 (5): 1232-1242.
3. Malerba M, Ragnoli B, Radaeli A, Tantucci C. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest. 2008; 134 (4): 733-739.
4. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med. 2002; 166(12 pt 2):S31-S37.
5. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol. 2004; 114 (5): 1241-1256.
6. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171 (8): 912-930.
7. Usmani OS, Barnes PJ. Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Ann Med. 2012; 44 (2): 146-156.
8. Usmani OS. Treating the small airways. Respiration. 2012; 84 (6): 441-453.
9. Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the F eno type trial. Chest. 2012; 142 (6): 1553-1561.
10. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol. 1998; 85 (2): 653-666.
11. Lehtimäki L, Turjanmaa V, Kankaanranta H, Saarelainen S, Hahtola P, Moilanen E. Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates. Ann Med. 2000; 32(6): 417-423.
12. Berry M, Hargadon B, Morgan A, et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005; 25 (6): 986-991.
13. Gelb AF, George SC, Camacho F, Fraser C, Flynn Taylor C, Shakkottai S. Increased nitric oxide concentrations in the small airway of older normal subjects. Chest. 2011; 139 (2): 368-375.
14. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J. 2005; 26 (1): 52-59.
15. Suri R, Paraskakis E, Bush A. Alveolar, but not bronchial nitric oxide production is elevated in cystic fibrosis. Pediatr Pulmonol. 2007; 42 (12): 1215-1221.
16. Tiev KP, Hua-Huy T, Kettaneh A, et al. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma. Thorax. 2012; 67 (2): 157-163.
17. Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol. 2007; 102 (1): 417-425.
18. Statement on standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987; 136 (1): 225-244.
19. Kharitonov SA, Barnes PJ. Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding. Thorax. 1997; 52 (6): 540-544.
20. Paredi P, Loukides S, Ward S, et al. Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis. Thorax. 1998; 53(9): 775- 779.
21. Paredi P, Kharitonov SA, Barnes PJ. Direct methods for the measurement of nitric oxide. Monaldi Arch Chest Dis. 2001; 56 (1): 88-90.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1 (8476): 307-310.
23. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J. 2006; 27 (5): 951-956.
24. Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med. 2001; 163 (7): 1557-1561.
25. Gelb AF, Flynn Taylor C, Krishnan A, et al. Central and peripheral airway sites of nitric oxide gas exchange in COPD. Chest. 2010; 137 (3): 575-584.
26. Foresi A, Leone C, Olivieri D, Cremona G. Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome. Chest. 2007; 132 (3): 860-867.
27. Hyde RW, Geigel EJ, Olszowka AJ, et al. Determination of production of nitric oxide by lower airways of humans - theory. J Appl Physiol. 1997; 82 (4): 1290-1296.
28. Högman M, Strömberg S, Schedin U, Frostell C, Hedenstierna G, Gustafsson LE. Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements. Acta Physiol Scand. 1997; 159 (4): 345-346.
29. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flowdependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med. 1997; 155 (1): 260-267.
30. Chládková J, Senkerík M, Havlínová Z, Krcmová I, Chládek J. Alveolar concentration and bronchial flux of nitric oxide: two linear modeling methods evaluated in children and adolescents with allergic rhinitis and atopic asthma. Pediatr Pulmonol. 2012; 47 (11): 1070-1079.
31. Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2009;(4): CD006340.
32. Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy. 2009; 39(4): 478-490.
33. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343 (8890): 133-135.
34. Paredi P, Kharitonov SA, Leak D, et al. Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. Am J Respir Crit Care Med. 2000; 161 (4): 1247-1251.
35. Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J. 2000; 16 (4): 781-792.
36. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest. 2007; 131 (5): 1353-1362.
37. Grasemann H, Ratjen F. Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr Pharm Des. 2012; 18 (5): 726-736.